Abstract-Although the modern surgical era is highlighted by multiple technological advances and innovations, one area that has remained constant is the dependence of the surgeon's vision on white-light reflectance. This renders different body tissues in a limited palette of various shades of pink and red, thereby limiting the visual contrast available to the operating surgeon. Healthy tissue, anatomic variations, and diseased states are seen as slight discolorations relative to each other and differences are inherently limited in dynamic range. In the upcoming years, surgery will undergo a paradigm shift with the use of targeted fluorescence imaging probes aimed at augmenting the surgical armamentarium by expanding the "visible" spectrum available to surgeons. Such fluorescent "smart probes" will provide real-time, intraoperative, pseudo-color, high-contrast delineation of both normal and pathologic tissues. Fluorescent surgical molecular guidance promises another major leap forward to improve patient safety and clinical outcomes, and to reduce overall healthcare costs. This review provides an overview of current and future surgical applications of fluorescence imaging in diseased and nondiseased tissues and focus on the innovative fields of image processing and instrumentation.
I. INTRODUCTION

I
N recent years, advances in whole body imaging and diagnostics have enhanced patient selection for surgical interventions. Concomitant innovation in surgical technique and minimally invasive approaches with laparoscopic, endoscopic and robotic techniques has advanced many surgical procedures. In spite of innumerable advances, surgery still relies primarily on white-light reflectance. This approach does not allow differentiation between normal and diseased tissue beyond gross anatomical distortion or discoloration. The emerging field of fluorescent surgical imaging promises to be a powerful enhancement to traditional low-contrast white-light visualization, offering real-time pseudo-color delineation of complex anatomic structures. Improved visualization will lead to more complete removal of disease, decreased inadvertent injury to vital structures, and improved identification for repair of damaged tissues.
Fluorescence imaging for surgical guidance is a rapidly expanding field. A PubMed search for "fluorescence imaging" and "surgery" demonstrates the exponential growth of published efforts; with 36 articles in 1999 rising to over 300 in 2011. The volume of work relating to fluorescence imaging in cancer operations has similarly expanded over the last two decades. Despite this rising excitement, clinical trials have barely begun, [1] - [5] and much more translational effort will be required to harness this exciting technology. The complexity of fluorescent surgical molecular guidance necessitates a multidisciplinary approach as it progresses through development, testing, implementation, and widespread adoption. The future of fluorescence guided surgery depends on the parallel development of high-quality fluorescent compounds that perform specific identification roles, and on image processing and instrumentation to display the images.
A complete list of currently available fluorescent probes has recently been reviewed and will not be repeated here. [6] , [7] Discussions of probe biomechanics, and specific applications have also been reported recently. [6] , [8] - [16] The technical challenges of fluorescent probe development, image processing and instrumentation are immense. Creative ingenuity is required to realize the full potential of fluorescence guided surgery. This review offers a framework for conceptualizing fluorescence guided surgery by highlighting current and future surgical applications in diseased and nondiseased tissues. We also focus on the innovative fields of image processing and instrumentation, which strive to merge the traditional surgical visual field with fluorescent guidance. The discussion on these technologies will focus on fluorescent signal detection, signal-to-noise optimization, and display.
II. VISUALIZATION OF DISEASED AND NONDISEASED TISSUES-A CRITICAL PROBLEM
Surgical management of disease is an integral part of health care. The core goals of surgery are to repair, remove, or correct diseased tissues while limiting un-necessary damage to healthy structures. Achieving these goals allows optimal disease treatment while preserving form and physiological function. Successful surgery depends on multiple factors, first and foremost being visualization. Bringing targeted fluorescence imaging and into the operating room dramatically expands surgeons' visual capabilities, allowing them to see structures as they extend beyond the surface tissue; even prior to their actual physical exposure. Improved visualization with fluorescence labeling enables more complete resection of surgical disease, while protecting adjacent vital structures. Fig. 1 . Nerves, vessels and muscles are not easily differentiated from one another with white light reflectance imaging. Intraoperative view of a lymph node dissection in a patient's neck, showing that large blood vessels and nerve structures are difficult to differentiate from surrounding muscle with white-light reflectance alone (A). The carotid artery (red), jugular vein (blue) and vagus nerve (yellow) are highlighted in the schematic (B). The vagus nerve is a few millimeters across and represents the largest scale nerve that surgeons identify. The smallest nerves that surgeons must identify are less than a millimeter in diameter. Enhancing the visualization of tissues based on structure could be equated to "painting" tissues in the surgical field to look more like a multicolored anatomy textbook; where nerves are yellow, lymphatics green, veins blue, and arteries red (Fig. 1) .
In the images of a mouse facial nerve shown in Fig. 2 , we see a case of normal (nondiseased) facial nerve that is difficult to distinguish with white-light alone. Viewing this same surgical field using fluorescence guidance allows easy identification of the delicate tendrils of facial nerve as they course near and around structures which otherwise obscure the view. [17] Protecting fine nerves during surgery requires high-contrast visualization. Unintentional damage to these fine nerves means postoperative functional deficits or pain.
An example where unpredictable tumor growth leads to more aggressive surgical resection is shown in Fig. 3 . A squamous cell cancer is readily seen as gross structural distortion and discoloration on the side of the tongue. Successful surgical removal of this cancer depends on knowing the extent of the tumor cells. Beneath the surface where the cancer extends in an unpredictable growth pattern (Fig. 3, green line) , visual contrast no longer allows the surgeon to reliably see the tumor. Knowing the risk of leaving cancer cells behind, the surgeon makes an educated guess regarding the extent of cancer growth and makes cuts accordingly (Fig. 3, blue line) . The cut edges of the surgical specimen are checked with intraoperative pathological review which adds to operative time and cost. Still sometimes, the final pathology shows the undesirable finding of cancer cells at the edge of the cancer resection; a "positive margin."
An example where tumor cells can be invisible to the human eye, but readily seen with targeted fluorescence imaging can be seen in Fig. 4 . Fluorescent activatable cell-penetrating peptide (ACPP) was used in a mouse model of metastatic breast cancer. [18] Cancer cells that could have easily been left behind after surgery stand out in the fluorescence image. Fluorescent labeling of malignant cells would remove potential ambiguity of the cancer borders during surgical dissection where most tissues are varying shades of reds and pink, leading to more effective and safer surgery. In contrast to nonspecific visual enhancers like fluorescein and ICG, "smart probes" are fluorescently labeled agents targeted to a specific tissue type or biochemical process. This affords the possibility of true surgical molecular guidance. Targeted smart probes can work via adherence to tissue specific markers such as antibody recognition of cell surface antigens, [19] , [20] peptide or aptamers with increased affinity for cell surface proteins [17] , [21] or through specific enzymatic localization and amplification. [18] , [22] - [34] Both traditional fluorescent visual enhancers and fluorescently labeled-smart probes increase the contrast across key tissue types to augment the surgeon's visualization over traditional white-light reflectance modalities.
IV. CLINICAL NEED AND APPLICATIONS
A. Non-Diseased Tissues/Structural Targets
In any surgical procedure, accurate identification and preservation of normal structures is critical to avoid iatrogenic injury. Most fluorescent agents that highlight nondiseased tissues take advantage of structural characteristics or prevalent binding sites, and illuminate an entire structure or tissue-type. Probes highlighting nondiseased tissues would benefit trauma and reconstructive procedures, as well as any case where improved identification of vital structures would make surgery safer or more efficient.
Following trauma, the repair of injured bones, tissues, nerves, and vessels requires accurate identification of relevant structures in the context of distorted anatomy. Frequently, nerves and tissues encountered in the surgical dissection are not easily identified because of tissue edema, inflammatory changes, and/or scarring. In the case of traumatic motor nerve transection, the distal nerve-end may be identified with electromyography for a several days following injury. Unfortunately, this technique is not useful at later times, it cannot help identify the proximal nerve-end, and it is not useful for autonomic and sensory nerves. This is just one realm where fluorescent targeting of nerve tissue would powerfully augment traditional identification techniques. The identification of healthy nerves can be expanded to a myriad of surgeries where fine nerve anatomy portends increased risks for damage and visualizing and these structures can decrease morbidity. An overview of this and other structural applications for surgical fluorescent imaging is provided in Table I .
B. Diseased Tissues/Functional Targets
Diseased tissues offer unique opportunities for targeted molecular guidance using fluorescent smart probes. The broad surgical categories of infection, atherosclerosis, and neoplasms represent three realms of surgery that are well-suited for future fluorescence imaging applications.
i) Infection/Devitalized Tissue: In cases of infection or tissue ischemia, surgery is often used to excise devitalized tissue. Surgical debridement relies on white-light reflectance to determine which tissue is healthy, and which is nonviable or has vascular compromise. This technique has low sensitivity and specificity and can lead to excessive removal of healthy tissue. [35] In the setting of acute invasive fungal sinusitis, current management depends on aggressive, thorough debridement of all involved structures. The extent of excision is largely dictated by the gross appearance of tissues-described as subtle hues of grey amidst a sea of pink mucosa. The surgery relies on pathological sections of the surgical borders to assess the extent of fungal invasion. If fungal spread could be more sensitively detected in the operating room, surgery could spare adjacent un-involved structures and be more efficient. Targeted fluorescent probes could fulfill this need by illuminating necrotic tissue, or even fungal species themselves.
With a similar goal, fluorescein has been used in general surgery for some time to identify devitalized segments of intestine, but there is certainly room for improvement. Better visualization of infected, devitalized, and ischemic tissue would benefit surgeons of all specialties.
ii) Atherosclerosis: In addition to cancer, atherosclerosis is a major cause of morbidity and death worldwide. [36] The disruption of plaques during surgical treatment of atherosclerosis such as in carotid endarterectomy (removal of atherosclerotic plaques from the carotid arteries) and coronary artery bypass grafting (surgically adding another vessel to provide blood flow to different parts of the heart when the native artery is blocked), can cause an embolic stroke or a heart attack, respectively. While taking into account associated clinical factors, candidacy for these two procedures is largely anatomic in nature; dependent on the location and degree of vessel stenosis. [37] , [38] Plaquespecific factors such as likelihood of rupture are not easily predicted using current methods and are usually not part of the presurgical decision making process. Importantly, the majority of acute heart attack and stroke occur not as a gradual progression of increasing stenosis, but rather as a sudden event where the blood flow through a diseased vessel is abruptly disrupted from an acute embolic event. Thus, accurate identification of these "vulnerable" plaques in susceptible patients would mitigate unnecessary surgery in patients with stable plaques and identify patients at high risk of plaque rupture. [39] - [42] Furthermore, the ability to observe processes leading to vulnerable plaque formation can be applied to other noninvasive imaging modalities (CT, MRI, and ultrasound). [43] - [46] iii) Cancer: With the primary treatment modality for most solid cancer being surgery, [47] complete removal of all malignant cells is unquestionably essential. If all cancer cells are removed with surgery, the patient is cured of that cancer. Unfortunately, visual inspection using white-light reflectance has very low sensitivity for identifying malignant cells. This leads to a considerable amount of "educated guess-work" when it comes to the extent of tissue removal for a cancer surgery (see Fig. 3 ).
Molecularly targeted fluorescent probes would allow improved visualization of tumor extent and detection of cancer cells that may have otherwise been left in the patient if relying on white-light reflectance alone. The removal of lymph nodes that potentially harbor tumor cells (sentinel or regional lymph node dissection) is another frequently performed cancer surgery that would benefit from the fluorescent illumination of cancer cells. In the context of cancer surgery, the ability to accurately visualize tumor cells at the molecular level at both primary and metastatic sites will improve diagnostic accuracy, reduce unnecessary surgery, and improve completeness of resection. Details regarding specific probes can be found in a recent review, [6] and recent work in fluorescence guidance in diseased surgical processes is summarized in Table II .
V. INSTRUMENTATION
It is not practical to conduct surgery while viewing only the fluorescence of the contrast agent. Instead, fluorescence images should be superimposed continuously in real time and in precise spatial register with reflectance images showing the morphology of the normal tissue and the location of the surgical instruments. Large-scale implementation of fluorescent guided surgery in humans will require advances in signal detection, signal-to-noise optimization, and display.
A. Detection
White-light reflectance is inherently brighter than fluorescence, in that the fraction of incident photons returned by reflectance is much higher than that from fluorescence, even from a strongly labeled tissue. Also, fluorescence requires spectral separation between intense short-wavelength excitation and relatively dim longer-wavelength emission, filtered to remove reflected excitation wavelengths. The simplest but least flexible solution, feasible mainly for dyes excited in the violet or blue range, is to tailor excitation and emission filters to provide a mixture of reflectance and fluorescence directly visible by eye or a standard color camera. An early example was the visualization of the fluorescence ((Leica FL400-excitation at 380-420 nm, display at 480-720 nm and Zeiss OPMI Pentero-excitation 400-410 nm, display 620-710 nm) from protoporphyrin IX generated in tumors by systemic administration of the metabolic precursor, 5-aminolevulinic acid. [4] The red emission filter was deliberately made slightly leaky to violet so that normal tissue landmarks and surgical instruments were visible by violet reflectance while cancer tissue glowed red. Normal full color reflectance was sacrificed so that image processing could be completely avoided. Similarly, fluorescein fluorescence (excitation 488 nm, emission ) can be viewed with an excitation filter mainly passing blue but with some leakage of green and red, paired with an emission filter preferentially passing green but with slight leakage of blue and somewhat more of red. The leakages allow blue, green, and red reflectances to generate a white-light reflectance image with green fluorescence superimposed (Zeiss Pentero). The advantage of these approaches is that the only modification of standard equipment is the inclusion of judiciously tailored excitation and emission filters. The disadvantages are 1) inflexibility, in that the filters have to be optimized for a given tissue concentration of a given dye, 2) spectral distortion of the reflectance image (in the worst case, confinement to violet), and 3) complete reliance on the surgeon's subjective color discrimination to decide how much fluorescence is sufficient to warrant resection.
The next higher level of sophistication is to provide separate cameras for reflectance and fluorescence respectively, so that the gain of each can be separately controlled, and the reflectance camera does not have to look through the emission filter required by the fluorescence camera. This is the obvious approach when the fluorophore excitation and emission wavelengths are in the NIR, [8] , [48] because the surgical field can be illuminated with white visible light (400-650 nm) plus 760 nm in the case of indocyanine green. The reflectance camera sees the white-light reflectance but not the NIR, while the fluorescence camera sees the 800 nm emission through a suitable long-pass filter, so that the reflectance and fluorescence channels are independently adjustable in gain. [8] A bit more ingenuity is required when the fluorophore excitation and emission are at visible wavelengths. One solution is to confine the excitation to three narrow spectral lines of blue, green, and red, say 488, 543, and 633 nm [49] whose relative intensities are adjusted to generate a reasonable simulation of white-light for the reflectance camera to monitor. Ideally, one of these wavelengths should be optimal for exciting the fluorophore. Meanwhile the fluorescence camera looks through an emission filter selective for one or more of the wavelength gaps between the sharp excitation lines. Depending on the fluorophore, some sacrifice of emission band-pass is likely to be necessary to avoid interference from the next longer illumination line. Also, it is cumbersome to adjust the intensity of the fluorescence excitation relative to the other lines making up the white-light illumination. In our view, the best way to control reflectance and fluorescence independently is to alternate them at 15-25 Hz rather than rely on complex custom interference filters. [17] , [50] Light-emitting diodes are readily pulsed to provide 20-33 ms white-light followed by 20-33 ms fluorescence excitation. Light returning from the surgical field is split by a 90:10 neutral beam-splitter to monochrome fluorescence and color reflectance cameras, each of which integrates photons during its appropriate illumination period. The resolutions and sensor dimensions of the two cameras are matched to facilitate registration of their images. Simple image processing provides a continuous high-resolution display with an imperceptible lag time. Provided that the display is fast enough and has enough resolution, there is no difficulty operating while viewing the monitor rather than looking directly at the actual surgical field. This time-multiplexing approach allows the spectral characteristics and gains of the reflectance and fluorescence channels to be varied completely independently and therefore allows maximum flexibility to cope with different dyes and tissue concentrations during the same imaging session in the same patient. We also find it useful to insert polarizers into the white-light and reflectance channels to attenuate distracting specular reflections from shiny wet surfaces.
Fluorescence guided surgery is important across both "open" and "minimally invasive" procedures. The basic concepts of signal detection are the same for both applications. Wide-field detection comprises a camera directed into an open surgical field, as the surgeon operates with direct line-of-sight visualization. The resultant fluorescence image is displayed on a screen for the surgeon to refer to in real-time during the operation. Minimally invasive surgeries are performed with endoscopes, and the surgeon does not have direct line-of-sight into the surgical field. For minimally invasive applications, detection instrumentation must be miniaturized to adapt to the endoscopic setup. Signal strength decreases with the use of smaller and smaller endoscopes, requiring improved detection and signal optimization techniques.
B. Signal-to-Noise Optimization
An important area of refinement is to correct for variable attenuation and blooming of fluorescence by tissue absorbance and scattering. A first-order correction for attenuation, especially by tissue absorbance, is to divide the raw epifluorescence intensity by the reflected intensity of the excitation beam. [10] , [51] This correction can be applied at video rates and copes reasonably well with up to 3X variations in absorption. Scattering can cause a major overestimation of the lateral dimensions of a buried fluorescent volume and is a much more difficult effect to deconvolve. Methods have been proposed for tomographic reconstruction using laser scanning in epi-illumination mode which is the only practical geometry of illumination of a human patient. Unfortunately, such methods currently require acquisition times of several minutes and computational reconstruction times on the order of hours, so they are not yet practical to apply intraoperatively. [52] On the one hand, tomography represents a major technical challenge for future progress. On the other hand, the tissue being cut is inherently superficial at the moment of its resection, so that as long as disease is detectable at all, its optical clarity will improve as the surgeon dissects each successive plane.
C. Display
For the user interface display, the simple approach is to show the reflectance and fluorescence images side-by-side or alternating on a single monitor. We feel this imposes an unnecessary strain on the surgeon to mentally register the two images accurately. A better solution is to display the fluorescence in a pseudo-color such as green or aqua, normally never present in tissue, superimposed on the color reflectance image. [48] Simply averaging the reflectance and fluorescence pseudo-color images makes both look dim. We prefer to use the fluorescence intensity F as a transparency factor where the .
Here is the maximum allowed value of F, either auto-scaled from the actual image or preset by the user. There are times during the operation when the surgeon prefers to see just the standard reflectance image or the fluorescence image alone, so we provide a foot pedal for hands-free cycling between these two modes and the overlay mode.
A logical further extension is to provide a second fluorescence channel at another emission wavelength. One obvious purpose would be to visualize both diseased tissue to be resected (e.g., tumor) and normal tissue to be spared (e.g., nerve) effectively simultaneously, using two targeted agents operating at well-separated wavelengths. [17] Another application is to image probes whose emission spectrum shifts from one wavelength band to another upon biochemical activation. The most common mechanism for such probes is that they contain two fluorophores interacting by fluorescence resonance energy transfer (FRET), which quenches the shorter-wavelength donor dye while sensitizing its longer-wavelength acceptor partner. Cleavage of the linker between the probes disrupts FRET so that the emission spectrum reverts to that of the donor alone. Displaying a ratio of the two emission bands isolates the degree of cleavage while canceling out many factors such as probe concentration, tissue thickness, excitation intensity, absorbances that affect both wavelengths equally, and motion artifacts. Emission ratioing can thus significantly increase the sensitivity and specificity of tumor or atherosclerotic plaque detection, justifying the increased complexity of the probe molecules and instrumentation. [53] , [54] VI. CONCLUSION The principles of addressing diseased and abnormal tissues while preserving adjacent structures will forever stand as a central tenet of surgical practice. Minimally invasive surgical techniques have altered the mechanics of many procedures and surgical practice has to evolve along with these emerging technologies. Working through minimally invasive interfaces has sacrificed the tactile feedback of directly working with tissue and forced surgeons to rely even more heavily on tissue visualization. Thus, a medical specialty traditionally dependent on touch becomes more dependent on vision alone. Any real time improvement in the intraoperative visual differentiation between different tissue types would represent a significant advance.
We are entering an exciting era, because surgical fluorescence imaging promises to be this much-needed advance. Along with these advances, there remain challenges of defining clinical endpoints and identifying which patients/surgeries would most benefit from fluorescent navigation techniques. In addition to the molecular challenges of developing better fluorescent probes, signal detection, signal-to-noise optimization, and display considerations represent the current technologic obstacles to the realization of real-time, intraoperative, pseudo-color, high-contrast fluorescent guided surgery.
